scispace - formally typeset
R

Richard A. Flavell

Researcher at Yale University

Publications -  1389
Citations -  223064

Richard A. Flavell is an academic researcher from Yale University. The author has contributed to research in topics: Immune system & T cell. The author has an hindex of 231, co-authored 1328 publications receiving 205119 citations. Previous affiliations of Richard A. Flavell include National Institute for Medical Research & University of Michigan.

Papers
More filters
Journal ArticleDOI

In Vivo Evidence for the Contribution of Human Histocompatibility Leukocyte Antigen (Hla)-Dq Molecules to the Development of Diabetes

TL;DR: Direct in vivo evidence for the diabetogenic effect of this human MHC class II molecule is provided and a unique “humanized” animal model of spontaneous diabetes is provided.
Journal ArticleDOI

Regulatory role of B cells in a murine model of allergic airway disease.

TL;DR: A novel regulatory role for regional B cells in AAD is illustrated and a possible contributory role of B cells, along with other cell types, in the establishment of LIT is suggested.
Journal ArticleDOI

Regulation of c-Jun NH2-terminal Kinase ( Jnk) Gene Expression during T Cell Activation

TL;DR: It is demonstrated that JNK is regulated by a second, novel mechanism that contributes to the regulation of the JNK pathway to ensure proper control during the course of an immune response.
Journal ArticleDOI

Innate immune cells in inflammation and cancer.

TL;DR: Basic principles of innate immune cell functions in inflammation are outlined and how these functions converge upon cancer development are discussed.
Journal ArticleDOI

RIG-I-mediated Activation of p38 MAPK Is Essential for Viral Induction of Interferon and Activation of Dendritic Cells DEPENDENCE ON TRAF2 AND TAK1

TL;DR: The role and mechanisms of activation of the MAPK pathway in innate immune responses induced by Sendai virus, a negative sense single-stranded RNA virus, are investigated and it is observed that TRAF2 and TAK1 were essential for RIG-I-mediated activation of p38 MAPK.